cytosine has been researched along with Hemorrhage in 22 studies
Hemorrhage: Bleeding or escape of blood from a vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis." | 7.75 | Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. ( Castagnola, E; Cirillo, C; Cuzzubbo, D; Dallorso, S; Di Marco, E; Faraci, M; Lanino, E; Moroni, C; Morreale, G, 2009) |
| "We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis." | 3.75 | Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. ( Castagnola, E; Cirillo, C; Cuzzubbo, D; Dallorso, S; Di Marco, E; Faraci, M; Lanino, E; Moroni, C; Morreale, G, 2009) |
| "Early-onset cystitis is often due to chemotherapy agents, while cystitis that develops 10-14 days into therapy is often associated with infection with polyomavirus, such as BK virus." | 2.48 | Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. ( Mackey, MC, 2012) |
| "This glycine was located in strand 5B and was well conserved in other serpins." | 1.46 | Mutation in a highly conserved glycine residue in strand 5B of plasminogen activator inhibitor 1 causes polymerisation. ( Iwaki, T; Kanayama, N; Nagahashi, K; Suzuki-Inoue, K; Takano, K; Umemura, K; Urano, T, 2017) |
| "The efficacy of cidofovir for treatment of cowpox virus infection in BALB/c mice was investigated in an effort to evaluate new therapies for virulent orthopoxvirus infections of the respiratory tract in a small animal model." | 1.31 | Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. ( Bray, M; Huggins, JW; Kefauver, D; Martinez, M; Smee, DF; Thompson, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Uzay, A | 1 |
| Gündoğdu, Y | 1 |
| Koşan, B | 1 |
| Yetiş, T | 1 |
| Gür, H | 1 |
| Okuturlar, Y | 1 |
| Kartı, SS | 1 |
| Arora, R | 1 |
| Singh, M | 1 |
| Garg, A | 1 |
| Gupta, M | 1 |
| Gupta, N | 1 |
| Schneidewind, L | 1 |
| Neumann, T | 1 |
| Schmidt, CA | 1 |
| Krüger, W | 1 |
| Kwon, HJ | 1 |
| Kang, JH | 1 |
| Lee, JW | 1 |
| Chung, NG | 1 |
| Kim, HK | 1 |
| Cho, B | 1 |
| Rascon, J | 2 |
| Verkauskas, G | 1 |
| Pasauliene, R | 1 |
| Zubka, V | 1 |
| Bilius, V | 1 |
| Rageliene, L | 1 |
| Philippe, M | 1 |
| Ranchon, F | 1 |
| Gilis, L | 1 |
| Schwiertz, V | 1 |
| Vantard, N | 1 |
| Ader, F | 1 |
| Labussiere-Wallet, H | 1 |
| Thomas, X | 1 |
| Nicolini, FE | 1 |
| Wattel, E | 1 |
| Ducastelle-Leprêtre, S | 1 |
| Barraco, F | 1 |
| Lebras, L | 1 |
| Salles, G | 1 |
| Michallet, M | 2 |
| Rioufol, C | 1 |
| Sakurada, M | 1 |
| Kondo, T | 1 |
| Umeda, M | 1 |
| Kawabata, H | 1 |
| Yamashita, K | 1 |
| Takaori-Kondo, A | 1 |
| Iwaki, T | 1 |
| Nagahashi, K | 1 |
| Takano, K | 1 |
| Suzuki-Inoue, K | 1 |
| Kanayama, N | 1 |
| Umemura, K | 1 |
| Urano, T | 1 |
| Schultz, DA | 1 |
| Sagartz, JE | 1 |
| Huso, DL | 1 |
| Buller, RM | 1 |
| Faraci, M | 3 |
| Cuzzubbo, D | 1 |
| Lanino, E | 1 |
| Di Marco, E | 1 |
| Cirillo, C | 1 |
| Dallorso, S | 1 |
| Morreale, G | 1 |
| Moroni, C | 1 |
| Castagnola, E | 1 |
| Cesaro, S | 2 |
| Hirsch, HH | 2 |
| Owoc-Lempach, J | 1 |
| Beltrame, A | 1 |
| Tendas, A | 1 |
| Baltadakis, I | 1 |
| Dalle, JH | 1 |
| Koc, Y | 1 |
| Toporski, J | 2 |
| Styczynski, J | 1 |
| Yesilipek, MA | 1 |
| Heinz, W | 1 |
| Caniglia, M | 1 |
| Fauser, AA | 1 |
| Lopez-Corral, L | 1 |
| Neuburger, S | 1 |
| Tridello, G | 2 |
| Einsele, H | 1 |
| Gaziev, J | 1 |
| Paba, P | 1 |
| Miano, R | 1 |
| Germani, S | 1 |
| Sodani, P | 1 |
| Bove, P | 1 |
| Perno, CF | 1 |
| Marziali, M | 1 |
| Gallucci, C | 1 |
| Isgrò, A | 1 |
| Paciaroni, K | 1 |
| Roveda, A | 1 |
| Simone, MD | 1 |
| De Angelis, G | 1 |
| Alfieri, C | 1 |
| Lucarelli, G | 1 |
| Mackey, MC | 1 |
| Koskenvuo, M | 1 |
| Dumoulin, A | 1 |
| Lautenschlager, I | 1 |
| Auvinen, E | 1 |
| Mannonen, L | 1 |
| Anttila, VJ | 1 |
| Jahnukainen, K | 1 |
| Saarinen-Pihkala, UM | 1 |
| Pillon, M | 1 |
| Aljurf, M | 1 |
| Martino, R | 1 |
| Schroyens, W | 1 |
| Nozzoli, C | 1 |
| Barba, P | 1 |
| Fagioli, F | 1 |
| Cappelli, B | 1 |
| Cordonnier, C | 1 |
| Al-Mohareb, F | 1 |
| Floisand, Y | 1 |
| Greil, J | 1 |
| Panizzolo, IS | 1 |
| Santarone, S | 1 |
| Fanourgiakis, P | 1 |
| Georgala, A | 1 |
| Vekemans, M | 1 |
| Triffet, A | 1 |
| De Bruyn, JM | 1 |
| Duchateau, V | 1 |
| Martiat, P | 1 |
| De Clercq, E | 1 |
| Snoeck, R | 1 |
| Wollants, E | 1 |
| Rector, A | 1 |
| Van Ranst, M | 1 |
| Aoun, M | 1 |
| Gorczynska, E | 1 |
| Turkiewicz, D | 1 |
| Rybka, K | 1 |
| Kalwak, K | 1 |
| Dyla, A | 1 |
| Szczyra, Z | 1 |
| Chybicka, A | 1 |
| Bridges, B | 1 |
| Donegan, S | 1 |
| Badros, A | 1 |
| Savona, MR | 1 |
| Newton, D | 1 |
| Frame, D | 1 |
| Levine, JE | 1 |
| Mineishi, S | 1 |
| Kaul, DR | 1 |
| Walker, BK | 1 |
| Raich, PC | 1 |
| Bray, M | 1 |
| Martinez, M | 1 |
| Smee, DF | 1 |
| Kefauver, D | 1 |
| Thompson, E | 1 |
| Huggins, JW | 1 |
| González-Fraile, MI | 1 |
| Cañizo, C | 1 |
| Caballero, D | 1 |
| Hernández, R | 1 |
| Vázquez, L | 1 |
| López, C | 1 |
| Izarra, A | 1 |
| Arroyo, JL | 1 |
| de la Loma, A | 1 |
| Otero, MJ | 1 |
| San Miguel, JF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population[NCT05317806] | Phase 4 | 15 participants (Anticipated) | Interventional | 2022-10-10 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for cytosine and Hemorrhage
| Article | Year |
|---|---|
Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation-A systematic review.
Topics: Administration, Intravenous; Administration, Intravesical; Adult; Antiviral Agents; BK Virus; Cidofo | 2018 |
Successful treatment with intravesical cidofovir for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A case report and a review of the literature.
Topics: Adenoviridae; Administration, Intravesical; Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; | 2016 |
Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis.
Topics: Administration, Intravesical; Antiviral Agents; Cidofovir; Cystitis; Cytosine; Hemorrhage; Humans; O | 2012 |
2 trials available for cytosine and Hemorrhage
| Article | Year |
|---|---|
Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir.
Topics: Adolescent; Adult; Anemia, Sickle Cell; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cyto | 2010 |
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation.
Topics: Adolescent; Adult; Allografts; Antiviral Agents; BK Virus; Child, Preschool; Cidofovir; Cystitis; Cy | 2013 |
17 other studies available for cytosine and Hemorrhage
| Article | Year |
|---|---|
Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug-Related Side Effects and Adverse Rea | 2023 |
Successful Treatment of BK Virus Hemorrhagic Cystitis (HC) Post Allogenic Hematopoietic Stem Cell Transplantation with Low Dose Cidofovir.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Hematopoietic Stem Cell Transplant | 2017 |
Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cystitis; Cytosine; Female; Hematopoietic | 2013 |
Intravesical cidofovir to treat BK virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation.
Topics: Administration, Intravesical; Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cystitis; Cy | 2015 |
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug Administration Schedule; Fema | 2016 |
Mutation in a highly conserved glycine residue in strand 5B of plasminogen activator inhibitor 1 causes polymerisation.
Topics: Aged; Amino Acid Substitution; Animals; Arginine; Chlorocebus aethiops; Conserved Sequence; COS Cell | 2017 |
Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus.
Topics: Animal Structures; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Hemorrhag | 2009 |
Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant.
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cytosine; Drug | 2009 |
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study.
Topics: Adolescent; Adult; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cytosin | 2009 |
BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial transmission.
Topics: Administration, Intravenous; Administration, Intravesical; Antiviral Agents; BK Virus; Bone Marrow T | 2013 |
Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient.
Topics: Adenoviridae; Adenovirus Infections, Human; Administration, Intravesical; Adult; Antiviral Agents; B | 2005 |
Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation.
Topics: Adenoviridae; Adolescent; Adult; Child; Child, Preschool; Cidofovir; Cystitis; Cytosine; Disease Man | 2005 |
Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation.
Topics: Administration, Intravesical; Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Hemo | 2006 |
Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Hematopoietic Stem Cell Tr | 2007 |
The treatment of acute leukemia in adults.
Topics: Adult; Agranulocytosis; Blood Transfusion; Bone Marrow Transplantation; Cytosine; Doxorubicin; Hemor | 1980 |
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Bronchi; Cidofovir; Cowpox; Cytosin | 2000 |
Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis.
Topics: Adolescent; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cystitis; Cytosine; Hemorrhage | 2001 |